Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Chief Discovery Officer acquired 35,000 shares (grant or award)
  2. 4 Grant or award Chief R&D Officer acquired 44,000 shares (grant or award)
  3. 4 Grant or award Chief Legal Officer acquired 75,000 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 115,000 shares (grant or award)
  5. 4 Grant or award Chief Medical Officer acquired 35,000 shares (grant or award)
  6. 4 Grant or award President & CEO acquired 123,000 shares (grant or award)
  7. UPLOAD Other SEC-generated Letter
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 8-K Event Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  17. 4 Insider Changes in Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations · Regulation FD disclosure
  20. 4 Insider Changes in Ownership

Page 20 of 99 · 1,967 filings